Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Reexamination Certificate
2007-06-20
2008-11-11
Wilson, James (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
C562S469000, C562S492000
Reexamination Certificate
active
07449495
ABSTRACT:
Described and claimed are compounds of Formula (I) in which R, R′, R″, A, and D have the meanings described in the text, as useful agents in the cure of pathologies characterized by altered angiogenesis and as antitumorals.
REFERENCES:
patent: 5547983 (1996-08-01), Charpentier
patent: 7053071 (2006-05-01), Dawson et al.
Zhang et al. Blood, 2002, 100(8), pp. 2917-2925.
Dawson, et al., An Adamantyl-Substituted Retinoid-Derived Molecule That Inhibits Cancer Cell Growth And Angiogenesis By Inducing Apoptosis And Binds To Small Heterodimer Partner Nuclear Receptor: Effects Of Modifying Its Carboxylate Group On Apoptosis, Proliferation, And Protein-Tyrosine Phosphatase Activity, Journal of Medicinal Chemistry (2007) pp. A-R.
Tittley et al., J. Med. Chem. (1989) vol. 32, pp. 1814-1820.
RN 146966-12-3 CAPLUS.
Database Crossfire Beilstein Online. Database Accession No. 3358409 - Beilstein Institute zur Forderung der chemischen Wissenschaften, frankfurt am Main, DE; Abstract & Mudrovcic: Monatsh. Chem., vol. 34, 1913, p. 1428.
Database Crossfire Beilstein Online. Database Accession No. 7997805 - Beilstein Institute zur Forderung der chemischen Wissenschaften, IFranfurt am Main, DE; Abstract & Krestinina, T.B.: Russ. J. Org. Chem., vol. 33, No. 7, 1997, pp. 1044-1045.
Database Crossfire Beilstein Online. Database Accession No. 2663218 - Beilstein Institute zur Forderung der chemischen Wissenschaften, Frankfurt am Main, DE; Abstract & Rabiloud, G. et al: Bull. Soc. Chem. Fr., 1977, pp. 281-287.
Jefferson, et al., Biphenylcarboxamide Derivatives as Antagonists of Platelet-Activating Factor, J. Med. Chem., vol. 32, No. 8, 1989, pp. 1814-1820.
Charpenter, et al., Synthesis, Structure-Affinity Relationships, And Biological !Activities Of Ligands Binding To Retinoic Acid Receptor Subtypes, Journal Of Medicinal Chemistry, vol. 38, No. 26, 1995, pp. 4993-5006.
Dallavalle Sabrina
Giannini Giuseppe
Merlini Lucio
Penco Sergio
Pisano Claudio
Collison Angela M.
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
Valenrod Yevegeny
LandOfFree
Retinoid derivatives with antiangiogenic, antitumoral and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoid derivatives with antiangiogenic, antitumoral and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoid derivatives with antiangiogenic, antitumoral and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030119